Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -120,088 | -110,612 | -92,442 | -78,231 | -31,781 |
| Depreciation Amortization | 357 | 295 | 236 | 122 | 462 |
| Accounts receivable | -301 | -224 | 55 | 83 | N/A |
| Accounts payable and accrued liabilities | 4 | 2,150 | 1,138 | -1,224 | 1,582 |
| Other Working Capital | 44,439 | 60,771 | -1,066 | 14 | 1,649 |
| Other Operating Activity | 75,579 | 71,412 | 70,668 | 69,519 | -8,562 |
| Operating Cash Flow | $-10 | $23,792 | $-21,411 | $-9,717 | $-36,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -412 | -25 | -22 | -17 | -193 |
| Investing Cash Flow | $-412 | $-25 | $-22 | $-17 | $-193 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 98,888 | 97,686 | 97,460 | 96,861 | 11,986 |
| Common Stock Repurchased | -552 | -413 | -280 | -246 | -544 |
| Financing Cash Flow | $98,336 | $97,273 | $97,180 | $96,615 | $11,442 |
| Beginning Cash Position | 42,803 | 42,803 | 42,803 | 42,803 | 68,204 |
| End Cash Position | 140,717 | 163,843 | 118,550 | 129,684 | 42,803 |
| Net Cash Flow | $97,914 | $121,040 | $75,747 | $86,881 | $-25,401 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10 | 23,792 | -21,411 | -9,717 | -36,650 |
| Capital Expenditure | -412 | -25 | -22 | -17 | -193 |
| Free Cash Flow | -422 | 23,767 | -21,433 | -9,734 | -36,843 |